Bullous Pemphigoid in Children: Sustained 8-Year Remission After Short-Course Corticosteroid Therapy. [PDF]
ABSTRACT This article reports a case of bullous pemphigoid (BP) in a 5‐year‐old child who achieved sustained remission for up to 8 years following short‐course systemic corticosteroid therapy, aiming to provide observational evidence for the clinical management of childhood BP. The child initially presented with pruritic rashes and blisters, which were
Wang F, Li H, Xu Y, Wang W.
europepmc +2 more sources
Rituximab for the Management of an Australian Cohort of Treatment Refractory Mucous Membrane Pemphigoid. [PDF]
ABSTRACT Background Mucous membrane pemphigoid (MMP) has a broad range of clinical manifestations, from relatively benign self‐limiting oral lesions to significant scarring (cicatrizing) of the oral, nasal and ocular tissues with severe functional impairment and morbidity.
Jeffrey B +9 more
europepmc +2 more sources
First Reported Coexistence of Plasma Cell Gingivitis and Multiple Sclerosis: A Case Report. [PDF]
Background Plasma cell gingivitis (PCG) is a rare, benign inflammatory condition of the oral mucosa characterized histologically by a dense plasmacytic infiltrate. Its etiology remains uncertain, with proposed triggers including allergens, infectious agents, and idiopathic immune reactions.
Tahernia H +3 more
europepmc +2 more sources
Angina Bullosa Hemorrhagica: A Rare Case Involving the Ventral Tongue. [PDF]
ABSTRACT Angina bullosa hemorrhagica (ABH) is a rare benign condition characterized by the sudden onset of hemorrhagic blisters in the oral mucosa, often triggered by minor trauma. We report a case of ABH in a 55‐year‐old woman with a history of asthma managed with inhaled corticosteroids who presented with a painful blister on the ventral tongue, an ...
Khajehzadeh F.
europepmc +2 more sources
ABSTRACT Aims This systematic review assesses current evidence on the management of non‐plaque (dental biofilm)‐induced gingival diseases and conditions (NPIGDs), including (i) inflammatory and immune conditions, (ii) neoplasms and (iii) gingival pigmentations.
Maria Clotilde Carra +5 more
wiley +1 more source
Tocilizumab for severe and refractory mucous membrane pemphigoid
Elevated IL‐6 levels identified in mucous membrane pemphigoid support IL‐6 blockade, with tocilizumab demonstrating clinical benefit in nine patients with severe and refractory mucous membrane pemphigoid. Abstract Background Mucous membrane pemphigoid (MMP) is a rare autoimmune blistering disease involving mucous membranes with a potentially ...
Billal Tedbirt +20 more
wiley +1 more source
An unusual case of benign mucous membrane pemphigoid
This case of benign mucous membrane pemphigoid (BMMP) is unusual in that blistering, scarring lesions were confined to the skin for 15 years before mucous membranes were involved. The onset of this disorder at the age of 38 is also unusual. Detailed immunological investigation was performed on this patient but the results in no way clarify the present ...
C I, Harrington, I B, Sneddon
openaire +2 more sources
Diagnostic Delay in Desquamative Gingivitis: An Observational Cohort Study
ABSTRACT Objectives Non‐plaque‐induced gingivitis encompasses a heterogeneous group of conditions as defined in the 2017 Classification of Periodontal and Peri‐Implant Diseases and Conditions. Recognition is challenging and often leads to diagnostic delay.
Alessandra Caggiula +5 more
wiley +1 more source
Analgesic effects of platelet‐rich fibrin (PRF): A systematic review
Abstract Background Platelet‐rich fibrin (PRF), a second‐generation autologous platelet concentrate, has gained significant interest for its anti‐inflammatory and regenerative characteristics. While its role in tissue healing is well‐recognized, the analgesic potential of PRF remains under‐investigated.
Nathan E. Estrin +6 more
wiley +1 more source
Gingival and Periodontal Diseases and Conditions in Children and Adolescents: Consensus Report
ABSTRACT Background The objectives of this Focused Workshop were to update the epidemiology, aetiology, risk factors, diagnosis and management of gingival and periodontal diseases and conditions in children and adolescents, and to explore the applicability of the 2018 Classification in children and adolescents.
Iain Chapple +30 more
wiley +1 more source

